Dr. Almand Joseph Westbrook Jr., a Mobile physician identified in medical board complaint records as associated with ADHD Medical Clinic of Mobile, faced scrutiny from the Alabama Board of Medical Examiners after a former patient accused him of abruptly ending ADHD treatment, refusing further prescriptions, and leaving the patient without specialist care for roughly two months.
The complaint alleged that the patient first saw Dr. Westbrook on or about October 26, 2015, after reporting symptoms that could be related to attention-deficit/hyperactivity disorder. According to the complaint, the patient was tested, evaluated, diagnosed with ADHD, and prescribed Adderall XR 10 mg. The complaint states that the patient remained under Westbrook’s care for about eight months and received six prescriptions for Adderall XR in 10 mg and 20 mg doses.
Then, according to the complaint, the relationship ended suddenly.
The patient alleged that on August 10, 2016, he called Westbrook’s office about a refill and spoke with a staff member identified as “Charlotte.” The complaint says the call was recorded and alleges that the patient was told the office would not issue another prescription and that it was in his “best interest” to find another physician for ADHD medication. The patient further alleged that he asked to speak directly with Dr. Westbrook but was told he could not do so.
A same-day termination letter from Medical Clinic of Mobile sharpened the dispute. In that letter, Westbrook wrote that he would “no longer be your ADHD physician” and that “effective immediately no treatment will be rendered” from his office. The letter told the patient to consult his primary care physician about ADHD treatment and said names of other physicians could be obtained through medical societies, hospital referral services, and insurance companies.
That language is the heart of the controversy. The dispute was not merely that a doctor ended a patient relationship. The complaint alleged that the termination came without adequate transition planning, without the patient being allowed to speak with the treating physician, and without continued treatment for a diagnosed condition involving a controlled prescription medication. The patient alleged he was unable to find another specialist and secure an appointment for two months, leaving him untreated during that period.
On January 18, 2017, the patient sent Dr. Westbrook a preservation-of-evidence and litigation-hold letter, putting him on notice of a potential malpractice action related to the patient’s diagnosis and treatment, or alleged lack of treatment, in 2015 and 2016. The letter demanded preservation of documents, notes, writings, emails, records, and other materials relating to the patient.
That same date, the patient signed a complaint authorization allowing the Alabama Board of Medical Examiners to obtain his complete medical record from Westbrook, including charts, prescriptions, notes, reports, audio tapes, and other materials relating to his care. The complaint named Almand Joseph Westbrook Jr., listed as MD.29047, and asked the board to investigate the conduct.
The board’s later response confirms that the matter did not simply disappear into a filing cabinet. In a March 15, 2017 letter, Senior Investigator Ed Munson Jr. wrote that the complaint had been reviewed by the board’s Director of Investigations, Stan Ingram, and by Munson. The letter stated that the board interviewed Dr. Westbrook, obtained a written response from him, and reviewed medical information authorized by the patient’s signed release.
That means the board took investigative steps. Westbrook was not merely named in a complaint; according to the board’s own letter, he was interviewed, asked for a written response, and his records were reviewed by investigators.
Munson wrote that investigative files are privileged and confidential, and said the board could not provide the specific information obtained.
That answer may have closed the regulatory door, but it did not erase the underlying questions. When a physician diagnoses a patient, prescribes controlled ADHD medication for months, and then ends care immediately, what obligation exists to ensure continuity? Is telling a patient to consult a primary care physician enough? Should a patient being treated for ADHD be cut off through office staff and a form letter, without direct physician communication? And if the patient cannot find replacement care for two months, who bears responsibility for the gap?
The records show a clash between regulatory limits and patient expectations. The board appeared to view the matter as a physician’s decision to end a relationship, not as discipline-worthy abandonment. The patient viewed it as an abrupt cutoff from ongoing treatment after months of care. Both cannot be reduced to the same bland phrase: “patient dismissal.”
The hard fact is this: according to the board’s own response, Dr. Almand Westbrook Jr. was the subject of a medical board complaint serious enough to trigger review by the Director of Investigations, an interview with the doctor, a written response from the doctor, and review of medical records. The board ultimately said it would not intervene, but the complaint placed a spotlight on how ADHD patients can be left exposed when a specialist ends treatment suddenly and leaves the patient to navigate the next step alone.